Multiple Myeloma
Multiple Myeloma is the indication for 26 drugs in DrugBank. It is covered by 72 curated, structured indications.
- Also known as
- Myelomatosis · Plasma cell myelomas · Myeloma · Plasma Cell Myeloma · Multiple Myeloma (MM)
- Indicated drugs
- Bortezomib
- Chymotrypsin
- Ciltacabtagene autoleucel
- Cyclophosphamide
- Daratumumab
- Denosumab
- Dexamethasone
- Doxorubicin
- Etoposide
- Hyaluronidase (human recombinant)
- Iberdomide
- Interferon alfa-2a
- Isatuximab
- Ixazomib
- Lenalidomide
- Lidocaine
- Melphalan
- Motixafortide
- Pamidronic acid
- Plerixafor
- Pomalidomide
- Prednisone
- Selinexor
- Thalidomide
- Vincristine
Resolves to
Vocabularies
What you can answer from here — as of October 20, 2026
72Structured indicationsPopulation, line of therapy, route and combination as fields, not proseSign in
Which approved drugs for Multiple Myeloma share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account